4月9日电，香港交易所信息显示，摩根士丹利在药明联合的持股比例于04月02日从1.67%升至5.75%。

Group 1 - Morgan Stanley increased its stake in WuXi AppTec from 1.67% to 5.75% as of April 2 [1]